Events

Reset
  • 04/10/2019

    Dosing complete in phase I clinical trial of ultra-rapid acting insulin product candidate AT247 for diabetes

  • 06/08/2019

    Arecor welcomes discussion with Mrs Kemi Badenoch, MP for Saffron Walden

  • 09/07/2019

    Arecor signs a new formulation evaluation agreement with an existing partner, a major global pharmaceutical company